Reflectance confocal microscopy (RCM) is a high-resolution, noninvasive imaging technique that is being increasingly utilized as an aid to diagnosis in the dermatologic setting. In 2008, RCM was approved by the US Food and Drug Administration (FDA) “for review by physicians to assist in forming a clinical judgment.”1 In 2015, the American Medical Association Current Procedural Terminology and Specialty Society Relative Value Scale Update (AMA CPT and RUC) committees assigned and approved a billable code for RCM examination, which is likely a harbinger for more routine use of RCM technology in everyday dermatologic practice.
|Original language||English (US)|
|Title of host publication||Reflectance Confocal Microscopy of Cutaneous Tumors, Second Edition|
|Number of pages||15|
|State||Published - Jan 1 2017|
ASJC Scopus subject areas